Company profile
Alcresta Therapeutics
Fulfilling potential: With the Science of Enzymes
- Industry
- Medical Equipment Manufacturing
- Employees
- 106
- Headquarters
- Waltham, Massachusetts
- Founded
- 2011
- LinkedIn followers
- 3,384
- Office locations
- 1
Alcresta Therapeutics company summary
Alcresta Therapeutics is a company in the Medical Equipment Manufacturing industry, headquartered in Waltham, Massachusetts, founded in 2011. On LinkedIn the company has around 106 employees and 3,384 followers.
What technology does Alcresta Therapeutics use?
No technologies detected yet. Warmrank rechecks company websites on a rolling basis.
About Alcresta Therapeutics
Alcresta Therapeutics is dedicated to developing and commercializing novel, enzyme-based products designed to address challenges faced by people living with gastrointestinal disorders and rare diseases. The company uses its proprietary technology platform to support a broad pipeline of products, with an initial focus on pancreatic insufficiency or fat malabsorption, which results in malabsorption common in cystic fibrosis, digestive cancers, preterm birth, and other serious diseases. The company’s lead product, RELiZORB®, is designed to reliably and efficiently deliver the optimal nutritional and caloric benefit from existing enteral feeding formulas by improving the breakdown and absorption of fats, in particular long-chain polyunsaturated fatty acids like omega-3 (including DHA, EPA). RELiZORB is indicated for use in pediatric (including neonates and infants) patients and adult patients to hydrolyze fats in enteral nutrition. The company’s platform is supported by our extensive experience in pharmaceutical, medical device and nutritional product development. Based in Massachusetts, the company is backed by Linden Capital Partners and HealthQuest Capital.
Where is Alcresta Therapeutics located?
Alcresta Therapeutics lists 1 location.
Compare companies similar to Alcresta Therapeutics
More companies in Medical Equipment Manufacturing.
| Company | Industry | Employees | Founded | Headquarters |
|---|---|---|---|---|
Alcresta Therapeutics alcresta.com | Medical Equipment Manufacturing | 106 | 2011 | Waltham, Massachusetts |
 Boston Scientific bostonscientific.com | Medical Equipment Manufacturing | 54,970 | - | Marlborough, MA |
 BD bd.com | Medical Equipment Manufacturing | 46,224 | - | Franklin Lakes, New Jersey |
 Baxter International Inc. baxter.com | Medical Equipment Manufacturing | 39,218 | - | Deerfield, Illinois |
 Alcon alcon.com | Medical Equipment Manufacturing | 27,667 | - | Geneva, Switzerland |
 Smith+Nephew smith-nephew.com | Medical Equipment Manufacturing | 19,271 | - | Watford, Hertfordshire, GB |
 Zimmer Biomet EMEA zimmerbiomet.com | Medical Equipment Manufacturing | 19,125 | - | Warsaw, Indiana |
 Olympus Corporation olympus-global.com | Medical Equipment Manufacturing | 13,703 | 1919 | Shinjuku-ku, Tokyo |
 Intuitive intuitive.com | Medical Equipment Manufacturing | 13,091 | 1995 | California, 94086 |
 Medline Australia medline.com | Medical Equipment Manufacturing | 18,899 | - | Northfield, IL |
 Edwards Lifesciences edwards.com | Medical Equipment Manufacturing | 14,197 | 1958 | Irvine, CA |
Frequently asked questions about Alcresta Therapeutics
What does Alcresta Therapeutics do?
Alcresta Therapeutics is dedicated to developing and commercializing novel, enzyme-based products designed to address challenges faced by people living with gastrointestinal disorders and rare diseases. The company uses its proprietary technology platform to support a broad pipeline of products, with an initial focus on pancreatic insufficiency or fat malabsorption, which results in malabsorption common in cystic fibrosis, digestive cancers, preterm birth, and other serious diseases. The company’s lead product, RELiZORB®, is designed to reliably and efficiently deliver the optimal nutritional and caloric benefit from existing enteral feeding formulas by improving the breakdown and absorption of fats, in particular long-chain polyunsaturated fatty acids like omega-3 (including DHA, EPA). RELiZORB is indicated for use in pediatric (including neonates and infants) patients and adult patients to hydrolyze fats in enteral nutrition. The company’s platform is supported by our extensive experience in pharmaceutical, medical device and nutritional product development. Based in Massachusetts, the company is backed by Linden Capital Partners and HealthQuest Capital.
How many employees does Alcresta Therapeutics have?
Alcresta Therapeutics has around 106 employees on LinkedIn.
Where is Alcresta Therapeutics headquartered?
Alcresta Therapeutics is headquartered in Waltham, Massachusetts.
When was Alcresta Therapeutics founded?
Alcresta Therapeutics was founded in 2011.
Build a lead list from companies like Alcresta Therapeutics
Describe your ICP or import a CSV. Warmrank finds matching companies, enriches contacts with verified emails, and tracks every lead.